Loading...
Market
Will Bavarian Nordic complete the production of 500,000 Jynneos doses for African countries by December 31, 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official press release from Bavarian Nordic or U.S. government announcement
Story
Biden: Bavarian Nordic Secures USD 63 Million U.S. Contract for Jynneos Mpox Vaccine
Sep 24, 2024, 03:57 PM
Bavarian Nordic has been awarded a USD 63 Million contract by the U.S. government to produce additional bulk product and final freeze-dried doses of its mpox and smallpox vaccine, Jynneos. This order is part of the U.S. effort to combat the mpox outbreak in Africa, with President Biden emphasizing the need for swift action, stating 'let's move quickly'. The U.S.-donated doses will primarily come from a stockpile in the United States, adding to the 60,000 previously donated shots. Bavarian Nordic is currently producing 500,000 doses for African countries.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 50,000 • 25%
50,000 to 99,999 • 25%
100,000 to 150,000 • 25%
More than 150,000 • 25%
Nigeria • 25%
Kenya • 25%
South Africa • 25%
Other • 25%
Less than 1 million • 25%
1 to 3 million • 25%
3 to 5 million • 25%
More than 5 million • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
